Matrikines in lung inflammation

R. Snelgrove (London, United Kingdom)

Source: ERS Lung Science Conference 2018
Number: 11
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Snelgrove (London, United Kingdom). Matrikines in lung inflammation. ERS Lung Science Conference 2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012

PAR-2 agonists induce TGF-beta and EMT leading to lung fibrosis
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013

P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019


The role of macrophages in interstitial lung diseases
Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017
Year: 2017



The role of chemokines and cytokines in lung fibrosis
Source: Eur Respir Rev 2008; 17: 151-156
Year: 2008



Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases
Source: Eur Respir J, 55 (3) 1900933; 10.1183/13993003.00933-2019
Year: 2020



Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing
Source: Eur Respir J 2004; 24: 502-505
Year: 2004



The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases
Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases
Year: 2005

The lung epithelial clock and its role in lung inflammation
Source: International Congress 2017 – The circadian molecular clock in respiratory diseases and associated interventions
Year: 2017


Nintedanib inhibits pro-fibrotic mediators from T cells with relevance to connective tissue disease-associated interstitial lung disease
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017

FIZZ1: a new pathway in silica-induced inflammatory mediators and pulmonary fibrosis
Source: International Congress 2018 – Occupational and environmental lung diseases: mechanisms, biomarkers and causation
Year: 2018

Enhanced lung inflammatory response to intratracheal CpG-ODN in mice with bleomycin-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011

Alveolar macrophage proteinase/antiproteinase expression in lung function and emphysema
Source: Eur Respir J 2014; 43: 82-91
Year: 2004



Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease
Source: Eur Respir Monogr 2022; 95: 219-237
Year: 2022


Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


The role of chronic inflammation in mouse lung tumourigenesis
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005